GRTX
Galera Therapeutics Inc

4,824
Mkt Cap
$16.07M
Volume
112,712.00
52W High
$0.15
52W Low
$0.0151
PE Ratio
0.05
GRTX Fundamentals
Price
$0.1001
Prev Close
$0.0941
Open
$0.10
50D MA
$0.0749
Beta
0.27
Avg. Volume
737,286.33
EPS (Annual)
$1.51
P/B
1.51
Rev/Employee
$0.00
$1.63
Loading...
Loading...

About

Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. It is also involved in the prevention of radiation-induced toxicity, including mucositis and the treatment of fibrosis, and cancer. The company was founded by Robert A. Beardsley, Randy W. Weiss, and Dennis P. Riley in 2009 and is headquartered in Malvern, PA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3

Frequently Asked Questions

What is Market Cap of Galera Therapeutics Inc?
What is the 52-week high for Galera Therapeutics Inc?
What is the 52-week low for Galera Therapeutics Inc?
What is Galera Therapeutics Inc stock price today?
What was Galera Therapeutics Inc stock price yesterday?
What is the PE ratio of Galera Therapeutics Inc?
What is the Price-to-Book ratio of Galera Therapeutics Inc?
What is the 50-day moving average of Galera Therapeutics Inc?
How many employees does Galera Therapeutics Inc have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available

Latest GRTX News

View
No GRTX news at the moment.
Top Discussions

Advertisement|Remove ads.